SCHEDULE 13G/A 0001104659-23-127707 0001989492 XXXXXXXX LIVE 2 Common Stock, par value $0.005 per share 03/31/2025 0000748592 Ernexa Therapeutics Inc. 114082209 1035 Cambridge Street Suite 18A Cambridge MA 02141 Rule 13d-1(c) IAF, LLC SC 3255421.00 0.00 3255421.00 0.00 3255421.00 N 5.2 OO Row 11 is calculated based on 62,363,763 shares of the Common Stock of the Issuer outstanding as of May 7, 2025 as reported in the Issuer's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 filed with the Securities and Exchange Commission on May 7, 2025. The number of shares beneficially owned in Rows 5, 7 and 9 and the number of shares outstanding for purposes of Row 11 do not include shares that will be issued to the Reporting Person pursuant to that certain Securities Purchase Agreement dated as of March 31, 2025 between the Issuer and the purchasers identified on the signature pages thereto, including the Reporting Person, following the receipt of stockholder approval at the Issuer's annual meeting of stockholders to be held on June 2, 2025. Ernexa Therapeutics Inc. 1035 Cambridge Street Suite 18A Cambridge, MA, 02141 IAF, LLC c/o 115 Church Street, Charleston, South Carolina 29401 SC Y See Row 9 of the Reporting Person's cover page to this Schedule 13G. See Row 11 of the Reporting Person's cover page to this Schedule 13G. See Row 5 of the Reporting Person's cover page to this Schedule 13G. See Row 6 of the Reporting Person's cover page to this Schedule 13G. See Row 7 of the Reporting Person's cover page to this Schedule 13G. See Row 8 of the Reporting Person's cover page to this Schedule 13G. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. IAF, LLC /s/ Edward G. R. Bennett 05/14/2025